[Federal Register Volume 88, Number 221 (Friday, November 17, 2023)]
[Notices]
[Pages 80322-80323]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-25490]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel Clinical Trials Planning Program.
    Date: January 23, 2024.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute at Shady Grove, 9609 Medical 
Center Drive, Room 7W106, Rockville, Maryland 20850 (Virtual 
Meeting).
    Contact Person: Eduardo Emilio Chufan, Ph.D. Scientific Review 
Officer, Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W106, Rockville, Maryland 20850 240-276-7975, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Metastasis Research Network (U01).
    Date: February 1, 2024.
    Time: 11:00 a.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W606, Rockville, Maryland 20850 (Virtual 
Meeting).
    Contact Person: Bruce Daniel Hissong, Ph.D. Scientific Review 
Officer, Resource and Training Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W606 Rockville, Maryland 20850, 240-276-7752, 
[email protected].

    Name of Committee: National Cancer Institute, Special Emphasis 
Panel, Diet, Lipid Metabolism, and Tumor Growth and Progression.
    Date: February 1, 2024.
    Time: 9:30 a.m. to 4:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute at Shady Grove, 9609 Medical 
Center Drive, Room 7W248, Rockville, Maryland 20850 (Virtual 
Meeting).
    Contact Person: Shree Ram Singh, Ph.D., Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W248, Rockville, Maryland 20850, 240-672-6175, 
[email protected].

    Name of Committee: National Cancer Institute, Special Emphasis, 
Panel SEP-4: NCI Clinical and Translational Cancer Research.
    Date: February 6-7, 2024.
    Time: 10:00 a.m. to 6:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute at Shady Grove, 9609 Medical 
Center Drive, Room 7W264, Rockville, Maryland 20850, (Virtual 
Meeting).
    Contact Person: Ombretta Salvucci, Ph.D.,Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W264, Rockville, Maryland 20850, 240-276-7286, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis, 
Panel SEP-1: NCI Clinical and Translational Cancer Research.
    Date: February 7, 2024.
    Time: 9:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W108, Rockville, Maryland 20850, (Virtual 
Meeting).
    Contact Person: Clifford W. Schweinfest, Ph.D., Scientific 
Review Officer, Special Review Branch Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W108, Rockville, Maryland 20850, 240-276-6343, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, NCI SPORE (P50) Review SEP-I.
    Date: February 15-16, 2024.
    Time: 9:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute at Shady Grove, 9609 Medical 
Center Drive, Room 7W244, Rockville, Maryland 20850, (Virtual 
Meeting).
    Contact Person: John Paul Cairns, Ph.D., Scientific Review 
Officer, Research Programs Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W244, Rockville, Maryland 20850, 301-461-0303, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel NCI Outstanding Investigator Award (R35).
    Date: February 15-16, 2024.
    Time: 9:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W104, Rockville, Maryland 20850, (Virtual 
Meeting).
    Contact Person: David G. Ransom, Ph.D., Chief, Scientific Review 
Officer, Special

[[Page 80323]]

Review Branch, Division of Extramural Activities, National Cancer 
Institute, NIH, 9609 Medical Center Drive, Room 7W104, Rockville, 
Maryland 20850, 240-276-6351, [email protected].

    Name of Committee: National Cancer Institute Initial Review 
Group, Transition to Independence Study Section (I).
    Date: February 15-16, 2024.
    Time: 11:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute at Shady Grove, 9609 Medical 
Center Drive, Room 7W602 Rockville, Maryland 20850, (Virtual 
Meeting).
    Contact Person: Delia Tang, M.D., Scientific Review Officer, 
Resources and Training Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W602, Rockville, Maryland 20850, 240-276-6456. 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, SEP-10: NCI Clinical and Translational Cancer Research.
    Date: February 22-23, 2024.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W606, Rockville, Maryland 20850, (Virtual 
Meeting).
    Contact Person: Bruce Daniel Hissong, Ph.D., Scientific Review 
Officer, Resource and Training Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W606 Rockville, Maryland 20850, 240-276-7752. 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: November 14, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-25490 Filed 11-16-23; 8:45 am]
BILLING CODE 4140-01-P